Evaluation of biomarkers and surrogate endpoints in chronic disease /
Saved in:
Imprint: | Washington, D.C. : National Academies Press, c2010. |
---|---|
Description: | xx, 314 p. : ill. ; 23 cm. |
Language: | English |
Subject: | |
Format: | Print Book |
URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/8136510 |
Other authors / contributors: | Micheel, Christine. Ball, John, 1944- Institute of Medicine (U.S.). Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease. |
---|---|
ISBN: | 9780309151290 (pbk.) 0309151295 (pbk.) 9780309151306 (pdf) 0309151309 (pdf) |
Notes: | Includes bibliographical references. |
Summary: | "Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process."--Publisher's description. |


Similar Items
-
Evaluation of biomarkers and surrogate endpoints in chronic disease /
Published: (2010) -
Perspectives on biomarker and surrogate endpoint evaluation : discussion forum summary /
by: Mack, Alison
Published: (2011) -
Development and application of biomarkers /
by: Lundblad, Roger L.
Published: (2011) -
Biomarker : indicator of abnormal physiological process /
Published: (2018) -
The path from biomarker discovery to regulatory qualification /
Published: (2013)